Daily heart rate per step may capture exertion better than steps alone
A step count can flatter or mislead. Ten thousand steps taken at a casual pace on flat ground do not represent the same physiologic load as 10,000 steps climbed briskly on a hill, and wearable devices already know enough about daily movement and pulse to capture some of that difference.
A new study in the Journal of the American Heart Association tested whether a simple ratio, called daily heart rate per step or DHRPS, might do a better job than step count alone when estimating fitness and cardiometabolic risk. The calculation is straightforward: average daily heart rate divided by average daily step count. Lower values indicate more movement for each beat, while higher values suggest a higher heart rate for less ambulatory work.
The idea is biologically intuitive. A person who can move more while keeping heart rate relatively modest is probably demonstrating better cardiorespiratory efficiency, lower physiologic strain, or both. In contrast, a higher pulse paired with fewer steps may reflect deconditioning, autonomic stress, impaired exercise tolerance, or underlying disease burden. In that sense, DHRPS tries to summarize not just how much someone moves, but how hard the cardiovascular system has to work to produce that movement.
Nearly 7,000 participants generated more than 50 billion steps
The cohort included nearly 7,000 people with an average age of 55. Each wore a Fitbit that tracked steps and average daily heart rate over five years. Across that period, volunteers took more than 50 billion steps, giving investigators a very large stream of real-world activity data rather than a short snapshot from a treadmill session.
The participants were not a random slice of the general population. More than 70% were female and more than 80% were white, and they were likely more willing than average to monitor activity and health. Those characteristics matter because wearable-device studies often enroll people who are already interested in self-tracking and preventive care, which can narrow how broadly the findings apply.
Even with that caveat, the signal was consistent. Higher DHRPS scores were associated with a greater risk of type 2 diabetes, hypertension, coronary atherosclerosis, heart attack, heart failure, and stroke. The ratio outperformed either heart rate alone or step count alone in its associations with those outcomes.
One sentence captures the core result: more heart beats for fewer steps tracked with worse cardiometabolic status.
The ratio separated people into three risk bands
Investigators divided DHRPS into three categories: low at 0.0081 or lower, medium above 0.0081 but below 0.0147, and high at 0.0147 or higher. A worked example makes the math easy to follow. If an average daily heart rate is 80 and daily steps average 4,000, the DHRPS is 0.0200. If the same heart rate is paired with 6,000 steps, the ratio falls to 0.0133, a better value because the heart is doing the same average work while the body is covering more ground.
That framing matters at the bedside because step counts alone cannot distinguish between someone who strolls all day and someone who exercises at a pace that challenges the cardiovascular system. Heart rate adds a measure of physiologic demand. Combined, the two may offer a more realistic estimate of daily fitness than either metric by itself.
The study also linked higher DHRPS scores to poorer self-reported health. Among the 21 participants who underwent exercise stress testing, those with the highest scores had the lowest exercise capacity. The stress-test sample was tiny, but the direction of the finding fits the broader pattern: when the heart rate rises disproportionately to daily movement, exercise reserve may already be limited.
Why the ratio may reflect fitness and disease burden
From a physiologic standpoint, DHRPS is attractive because it merges two domains that often separate during early disease. Step counts quantify external work. Heart rate reflects internal effort. A person with better aerobic conditioning can usually sustain activity with less tachycardia, while someone with vascular disease, insulin resistance, hypertension, or heart failure may experience a higher pulse with less activity.
This does not mean the ratio diagnoses disease. It does suggest the ratio may serve as a compact marker of how efficiently the cardiovascular system is coping with ordinary daily demands. In a person with evolving atherosclerosis, impaired glucose metabolism, or reduced cardiac reserve, the heart may have to beat faster to support the same level of movement. That mismatch is exactly what DHRPS is designed to catch.
Still, causality remains unproven. The study can show an association between a higher ratio and disease, but it cannot show that the ratio itself causes diabetes, hypertension, stroke, or coronary events. A higher score may be a marker of illness rather than a driver of it.
Wearable data are promising, but the practical barriers remain real
The article raises a useful question for patients who already own a smartwatch or Fitbit: should they start calculating DHRPS? The answer is cautious, not enthusiastic. More research is needed before the ratio can be used as a validated tool for screening or prevention.
Several limitations keep the finding from immediate clinical adoption. The study did not compare DHRPS with standard cardiovascular risk factors such as family history or smoking. It also did not test the ratio against established cardiovascular risk calculators, so its added value over familiar office-based tools is still uncertain. The exercise testing subset was too small to support firm conclusions, and the devices needed for continuous heart-rate monitoring can cost hundreds of dollars.
A practical barrier sits right beside the statistical one: a ratio has little use if the technology required to calculate it is out of reach.
For now, the clearest use of DHRPS may be motivational. If a wearable prompt nudges someone to walk more, move briskly, or reduce sedentary time, that behavioral change could matter more than the number itself. But the study did not test whether knowing the ratio improves outcomes, and it did not show that acting on the ratio lowers disease risk.
What clinicians may take from the finding
The work fits a familiar clinical principle: not all movement is equal, and not all exertion is visible in a step counter. Heart rate adds a layer of intensity that can make wearable data more meaningful. In people already using devices that track both measures, DHRPS may eventually become a useful shorthand for daily cardiometabolic strain, especially if future studies show it predicts outcomes better than conventional activity metrics.
For now, it remains an intriguing measure rather than a standard of care. The central unanswered issue is not whether the ratio can be calculated, but whether acting on it changes health in a measurable way.